Distribution and density of specific high-affinity 125I-neurotensin-binding sites were examined by light microscopic radioautography in the suprachiasmatic nucleus (SCN) of normal cycling, ovariectomized, or ovariectomized and estradiol-implanted female rats. In all three experimental groups, intense 125I-neurotensin labeling was detected within the ventrolateral component of the SCN. Whereas the topographic distribution and spread of the label was similar between each group, the density of the label was significantly higher (mean increase: 122%) in ovariectomized than in normally cycling females within the rostral third of the SCN. This effect was no longer apparent in females chronically implanted with estradiol at the time of gonadectomy. These results indicate that plasma gonadal steroids may regulate neurotensin receptors in the rat SCN. It is suggested that this mechanism might be implicated in the feedback control of gonadotropin and prolactin secretion.

Keywords:
Neurotensin receptors, Gonadal steroids, Radioautography
This content is only available via PDF.
© 1988 S. Karger AG, Basel
1988
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.